Following the removal of a 30-cm tumor from his large intestine, Elliot Pfebve, a patient with colon cancer, was referred to the Queen Elizabeth Hospital Birmingham for chemotherapy and to participate in the clinical research.
The lecturer in higher education stated: “As a community-focused individual and member of my profession, I am aligned to participate in this study.
“I want to have a positive impact on other people’s lives and assist them in reaching their full potential. If this experiment is effective, it could benefit thousands or even millions of individuals, giving them hope.
Under a new initiative, thousands of additional NHS cancer patients in England will be enlisted to participate in vaccine trials for different types of cancer in the upcoming years, officials have announced.
After surgery to remove a tumor, the purpose of the jab is to boost the patient’s immune system so that it can identify and eliminate any cancer cells that may still be present.
The trial’s primary investigator, Dr. Victoria Kunene, a consultant clinical oncologist at Queen Elizabeth Hospital Birmingham, suggested that the results might represent a “significant and positive development for patients”.
